United Arab Emirates Fusion Biopsy Market Size & Outlook, 2026-2034


United Arab Emirates Fusion Biopsy Market Insights

  • Reed Intelligence analysis indicates that the United Arab Emirates Fusion Biopsy Market size, valued at USD 81.5 Million in 2025, is expected to expand to USD 187.25 Million by 2034.
  • The United Arab Emirates market is forecasted to expand at a CAGR of 9.79% spanning 2026–2034.
  • MRI-Ultrasound Fusion Biopsy held the leading position among By Type segments in 2025, based on market size.
  • Cognitive Fusion Biopsy is projected to post the fastest growth rate, sustaining its position as the most attractive By Type segment during the forecast horizon.

Other Key Findings


  • In 2025, United Arab Emirates accounted for 4.48% of the global Fusion Biopsy Market size.
  • By 2034, United States is expected to lead the global Fusion Biopsy Market in terms of market size.
  • Within Middle East and Africa, United Arab Emirates is projected to dominate the regional Fusion Biopsy Market size by 2034.
  • Turkey is identified as the fastest-growing market in Middle East and Africa, anticipated to reach USD 31.68 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 81.5 Million
Market Size In 2034 USD 187.25 Million
Largest segment MRI-Ultrasound Fusion Biopsy
Units Revenue in USD Million
CAGR 9.79% (2026-2034)
Segmnetation Covered
By Type
  1. MRI-Ultrasound Fusion Biopsy
  2. Cognitive Fusion Biopsy
  3. Transperineal Fusion Biopsy
By Application
  1. Prostate Cancer Diagnosis
  2. Focal Therapy Planning
  3. Active Surveillance Monitoring
By End Use
  1. Hospitals
  2. Diagnostic Imaging Centers
  3. Ambulatory Surgical Centers
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
clients
Trusted by Fortune 500
Over 30000+ subscribers